These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23959336)

  • 41. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
    Choi SH; Park TG
    Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A one-step modified method to reduce the burst initial release from PLGA microspheres.
    Zheng C; Liang W
    Drug Deliv; 2010 Feb; 17(2):77-82. PubMed ID: 20067365
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
    Chaw CS; Yang YY; Lim IJ; Phan TT
    J Microencapsul; 2003; 20(3):349-59. PubMed ID: 12881115
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chitin/PLGA blend microspheres as a biodegradable drug delivery system: a new delivery system for protein.
    Mi FL; Shyu SS; Lin YM; Wu YB; Peng CK; Tsai YH
    Biomaterials; 2003 Dec; 24(27):5023-36. PubMed ID: 14559016
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trehalose limits BSA aggregation in spray-dried formulations at high temperatures: implications in preparing polymer implants for long-term protein delivery.
    Rajagopal K; Wood J; Tran B; Patapoff TW; Nivaggioli T
    J Pharm Sci; 2013 Aug; 102(8):2655-66. PubMed ID: 23754501
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Facile fabrication of biocompatible PLGA drug-carrying microspheres by O/W pickering emulsions.
    Wei Z; Wang C; Liu H; Zou S; Tong Z
    Colloids Surf B Biointerfaces; 2012 Mar; 91():97-105. PubMed ID: 22088755
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery.
    Giovagnoli S; Blasi P; Schoubben A; Rossi C; Ricci M
    Int J Pharm; 2007 Mar; 333(1-2):103-11. PubMed ID: 17079101
    [TBL] [Abstract][Full Text] [Related]  

  • 48. pH-responsive release of proteins from biocompatible and biodegradable reverse polymer micelles.
    Koyamatsu Y; Hirano T; Kakizawa Y; Okano F; Takarada T; Maeda M
    J Control Release; 2014 Jan; 173():89-95. PubMed ID: 24200745
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Water-free microencapsulation of proteins within PLGA microparticles by spray drying using PEG-assisted protein solubilization technique in organic solvent.
    Mok H; Park TG
    Eur J Pharm Biopharm; 2008 Sep; 70(1):137-44. PubMed ID: 18515053
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stabilization and encapsulation of recombinant human erythropoietin into PLGA microspheres using human serum albumin as a stabilizer.
    He J; Feng M; Zhou X; Ma S; Jiang Y; Wang Y; Zhang H
    Int J Pharm; 2011 Sep; 416(1):69-76. PubMed ID: 21699969
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conjugates of poly(DL-lactide-co-glycolide) on amino cyclodextrins and their nanoparticles as protein delivery system.
    Gao H; Wang YN; Fan YG; Ma JB
    J Biomed Mater Res A; 2007 Jan; 80(1):111-22. PubMed ID: 16960831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gas foamed open porous biodegradable polymeric microspheres.
    Kim TK; Yoon JJ; Lee DS; Park TG
    Biomaterials; 2006 Jan; 27(2):152-9. PubMed ID: 16023197
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Controlled release of the fibronectin central cell binding domain from polymeric microspheres.
    Bouissou C; Potter U; Altroff H; Mardon H; Van Der Walle C
    J Control Release; 2004 Mar; 95(3):557-66. PubMed ID: 15023466
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of glycolic acid monomer ratio on the emulsifying activity of PLGA in preparation of protein-loaded SLN.
    Xie S; Wang S; Zhu L; Wang F; Zhou W
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):358-61. PubMed ID: 19717285
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insulin nanoparticle preparation and encapsulation into poly(lactic-co-glycolic acid) microspheres by using an anhydrous system.
    Han Y; Tian H; He P; Chen X; Jing X
    Int J Pharm; 2009 Aug; 378(1-2):159-66. PubMed ID: 19465100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preparation and characterization of poly(lactic-co-glycolic acid) microspheres loaded with a labile antiparkinson prodrug.
    D'Aurizio E; van Nostrum CF; van Steenbergen MJ; Sozio P; Siepmann F; Siepmann J; Hennink WE; Di Stefano A
    Int J Pharm; 2011 May; 409(1-2):289-96. PubMed ID: 21356295
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sustained release of platelet-derived growth factor and vascular endothelial growth factor from silk/calcium phosphate/PLGA based nanocomposite scaffold.
    Farokhi M; Mottaghitalab F; Ai J; Shokrgozar MA
    Int J Pharm; 2013 Sep; 454(1):216-25. PubMed ID: 23856159
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exploring polyvinylpyrrolidone in the engineering of large porous PLGA microparticles via single emulsion method with tunable sustained release in the lung: In vitro and in vivo characterization.
    Ni R; Muenster U; Zhao J; Zhang L; Becker-Pelster EM; Rosenbruch M; Mao S
    J Control Release; 2017 Mar; 249():11-22. PubMed ID: 28109773
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduction of structural perturbations in bovine serum albumin by non-aqueous microencapsulation.
    Carrasquillo KG; Carro JC; Alejandro A; Toro DD; Griebenow K
    J Pharm Pharmacol; 2001 Jan; 53(1):115-20. PubMed ID: 11206185
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stabilization of tetanus toxoid encapsulated in PLGA microspheres.
    Jiang W; Schwendeman SP
    Mol Pharm; 2008; 5(5):808-17. PubMed ID: 18710256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.